# Induced Pluripotent Stem Cells-derived Small Extracellular Vesicles May Promote Neurological Function and Improve Cognitive Impairment in Acute Ischemic Stroke Patients

> **NCT07145294** · PHASE1,PHASE2 · RECRUITING · sponsor: **Hongmei Wang** · enrollment: 40 (estimated)

## Conditions studied

- Cognitive Impairment

## Interventions

- **BIOLOGICAL:** iEV
- **OTHER:** Basic treatments

## Key facts

- **NCT ID:** NCT07145294
- **Lead sponsor:** Hongmei Wang
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-07
- **Primary completion:** 2025-07-30
- **Final completion:** 2026-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145294, "Induced Pluripotent Stem Cells-derived Small Extracellular Vesicles May Promote Neurological Function and Improve Cognitive Impairment in Acute Ischemic Stroke Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07145294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*